Nannan Ni serves as the Director of Finance Business Partnering at CSL Behring, where he plays a pivotal role in shaping the financial landscape of the organization. With over 15 years of diverse experience across the pharmaceutical, FMCG, mining, and healthcare sectors, Nannan has honed...
Nannan Ni serves as the Director of Finance Business Partnering at CSL Behring, where he plays a pivotal role in shaping the financial landscape of the organization. With over 15 years of diverse experience across the pharmaceutical, FMCG, mining, and healthcare sectors, Nannan has honed his expertise in management accounting, financial analysis, and strategic financial reporting. As a key member of the CSL Behring Australia Operational Leadership Team, he leads a dedicated Finance Business Partnering team that provides critical financial insights to support productivity improvement initiatives and enhance the financial performance of various projects.
In his current role, Nannan is responsible for delivering actionable financial analysis that informs executive decision-making and aligns with the company’s strategic objectives. He excels in driving process improvements and fostering collaboration among key stakeholders, ensuring that financial considerations are integrated into operational strategies. His ability to navigate complex financial landscapes, coupled with his proficiency in internal controls and contractor management, positions him as a trusted advisor to the executive teams.
Nannan's commitment to excellence is evident in his work on strategic plan updates, where he leverages insightful analytics to support business targets and drive sustainable growth. His comprehensive understanding of taxation and fixed asset management further enhances his capability to provide robust financial oversight. As CSL Behring continues to innovate within the biopharmaceutical industry, Nannan Ni remains at the forefront, ensuring that financial strategies not only support current operations but also pave the way for future advancements.